2018-10-21 14:40:00 Sun ET
treasury deficit debt employment inflation interest rate macrofinance fiscal stimulus economic growth fiscal budget public finance treasury bond treasury yield sovereign debt sovereign wealth fund tax cuts government expenditures
President Trump floats generous 10% tax cuts for the U.S. middle class ahead of the November 2018 mid-term elections. Republican senators, congressmen, and congresswomen can propose massive tax cuts for middle-income Americans. This time may be a bit different, and President Trump expects the tax bill to go through Congress but not an executive order. The Trump administration suggests that the legislative vote will likely take place soon after the mid-term elections. The strategic move boosts confidence in the Republican lawmakers who can continue to control Congress. Treasury Secretary Steven Mnuchin cannot offer details on the middle-income tax brackets that can experience lower effective tax rates. This tax bill may add to the prior $1.5 trillion tax cuts and $779 billion fiscal deficits.
Republican leaders and senators emphasize that this tax bill will finance itself with better real GDP economic growth in the healthy upper range of 3%-4%. The Trump administration can offset these new tax cuts with lower government expenditures in Medicare, Medicaid, and social security. Alternatively, the Trump administration can raise effective tax rates for most rich Americans in the top 1% socioeconomic echelon to partially offset the new tax cuts for the U.S. middle-class.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-04-17 11:34:00 Wednesday ET

Amazon CEO Jeff Bezos admits the fact that antitrust scrutiny remains a primary imminent threat to his e-commerce business empire. In his annual letter to A
2018-05-29 11:40:00 Tuesday ET

America and China, the modern world's most powerful nations may stumble into a **Thucydides trap** that Harvard professor and political scientist Graham
2018-08-27 09:35:00 Monday ET

President Trump and his Republican senators and supporters praise the recent economic revival of most American counties. The Economist highlights a trifecta
2020-04-24 11:33:00 Friday ET

Disruptive innovations tend to contribute to business success in new blue-ocean markets after iterative continuous improvements. Clayton Christensen and
2018-04-17 12:38:00 Tuesday ET

Value investment strategies make investors wiser like water with core fundamental factor analysis. Value investors tend to buy stocks below their intrinsic